|
| | Publication Year | Title | Author(s) |
| 621 | 18-Jul-2014 | Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling. | Robson, Neil C; Hidalgo, Laura; McAlpine, Tristan; Wei, Heng; Martínez, Víctor G; Entrena, Ana; Melen, Gustavo J; MacDonald, Andrew S; Phythian-Adams, Alexander; Sacedón, Rosa; Maraskovsky, Eugene; Cebon, Jonathan S ; Ramírez, Manuel; Vicente, Angeles; Varas, Alberto |
| 622 | 14-May-2021 | Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2. | Nguyen, William; Lee, Erinna F; Evangelista, Marco; Lee, Mihwa; Harris, Tiffany J ; Colman, Peter M; Smith, Nicholas A; Williams, Luke B; Jarman, Kate E; Lowes, Kym N; Haeberli, Cécile; Keiser, Jennifer; Smith, Brian J; Fairlie, Walter Douglas ; Sleebs, Brad E |
| 3 | Apr-2018 | Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations. | Colebatch, Andrew J; Witkowski, Tom ; Waring, Paul M; McArthur, Grant A; Wong, Stephen Q; Dobrovic, Alexander |
| 4 | Nov-2020 | Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer. | de Boer, Richard; Hui, Rina; Lim, Elgene; Yeo, Belinda ; Zdenkowski, Nicholas |
| 5 | Dec-2016 | Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists. | Atkinson, Victoria; Long, Georgina V; Menzies, Alexander M; McArthur, Grant; Carlino, Matteo S; Millward, Michael; Roberts-Thomson, Rachel; Brady, Benjamin; Kefford, Richard; Haydon, Andrew; Cebon, Jonathan S |
| 6 | Apr-2019 | Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts. | Yang, J C-H; Ramalingam, S S; Lee, C K; Kurata, T; Kim, D-W; John, Thomas ; Nogami, N; Ohe, Y; Rukazenkov, Y; Murphy, M; Jänne, P A |
| 7 | 2018 | Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer | Ramalingam, Suresh S; Yang, James C-H; Lee, Chee Khoon; John, Thomas ; Kurata, Takayasu; Nogami, Naoyuki; Ohe, Yuichiro; Kim, Dong-Wan; Mann, Helen; Rukazenkov, Yuri; Ghiorghiu, Serban; Stetson, Daniel; Markovets, Aleksandra; Barrett, J Carl; Thress, Kenneth S; Jänne, Pasi A |
| 8 | Oct-2020 | Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. | Wu, Yi-Long; Tsuboi, Masahiro; He, Jie; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S |
| 9 | Nov-2020 | Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. | Papadimitrakopoulou, V A; Mok, T S; Han, J-Y; Ahn, M-J; Delmonte, A; Ramalingam, S S; Kim, S W; Shepherd, F A; Laskin, J; He, Y; Akamatsu, H; Theelen, W S M E; Su, W-C; John, Thomas ; Sebastian, M; Mann, H; Miranda, M; Laus, G; Rukazenkov, Y; Wu, Y-L |
| 10 | 1-Jul-2017 | Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial. | Kühnl, A; Cunningham, D; Counsell, Nicholas; Hawkes, Eliza A ; Qian, W; Smith, P; Chadwick, N; Lawrie, A; Mouncey, P; Jack, A; Pocock, C; Ardeshna, Kirit M; Radford, J; McMillan, A; Davies, J; Turner, D; Kruger, A; Johnson, P W; Gambell, J; Rosenwald, A; Ott, G; Horn, H; Ziepert, M; Pfreundschuh, M; Linch, D |
| 11 | Jul-2018 | Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital. | Gleeson, Mary; Peckitt, Clare; Cunningham, David; Gibb, Adam; Hawkes, Eliza A ; Back, Morgan; Yasar, Binnaz; Foley, Kate; Lee, Rebecca; Dash, Joanna; Johnson, Hannah; O'Hara, Catherine; Wotherspoon, Andrew; Attygalle, Ayoma; Menasce, Lia; Shenjere, Patrick; Potter, Mike; Ethell, Mark E; Dearden, Claire; Radford, John; Chau, Ian; Linton, Kim |
| 12 | Aug-2017 | Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer. | Tamjid, Babak ; Phan, Phuong L; John, Thomas ; Mitchell, Paul L R ; Gan, Hui K |
| 13 | Aug-2017 | Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013. | Gleeson, Mary; Hawkes, Eliza A ; Peckitt, Clare; Wotherspoon, Andrew; Attygalle, Ayoma; Sharma, Bhupinder; Du, Yong; Ethell, Mark; Potter, Mike; Dearden, Claire; Horwich, Alan; Chau, Ian; Cunningham, David |
| 14 | 1-Sep-2023 | Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance. | Barraclough, Allison ; England, James T; Villa, Diego; Wight, Joel C ; Hapgood, Greg; Conn, Jason; Doo, Nicole Wong; Li, Eric Wenlong; Gilbertson, Michael; Shaw, Briony; Bishton, Mark J; Saeed, Malik; Ratnasingam, Sumita; Abeyakoon, Chathuri; Chong, Geoff; Wai, Shin Hnin; Ku, Matthew; Lee, Hui-Peng; Fleming, Kathryn; Tam, Constantine; Douglas, Genevieve ; Cheah, Chan Y; Ng, Zi Yun; Rolfe, Tukten; Mills, Anthony K; Hamad, Nada; Cashman, Helen; Gleeson, Mary; Narayana, Manjunath; Hawkes, Eliza A |
| 15 | Dec-2017 | Outcomes of endovascular treatment for acute large-vessel ischaemic stroke more than 6 h after symptom onset. | Motyer, R; Kok, H K; Asadi, Hamed ; O'Hare, A; Brennan, P; Power, S; Looby, S; Nicholson, P; Williams, D ; Murphy, S; Hill, M D; Goyal, M; McManus, J; O'Brien, P; Thornton, J |
| 16 | 8-Oct-2019 | Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance. | Tobin, Joshua W D; Rule, Gabrielle; Colvin, Katherine; Calvente, Lourdes; Hodgson, David; Bell, Stephen; Dunduru, Chengetai; Gallo, James; Tsang, Erica S; Tan, Xuan; Wong, Jonathan; Pearce, Jessica; Campbell, Robert; Tneh, Shao; Shorten, Sophie; Ng, Melissa; Cochrane, Tara; Tam, Constantine S; Abro, Emad; Hawkes, Eliza A ; Hodges, Georgina; Kansara, Roopesh; Talaulikar, Dipti; Gilbertson, Michael; Johnston, Anna M; Savage, Kerry J; Villa, Diego; Morris, Kirk; Ratnasingam, Sumi; Janowski, Wojt; Kridel, Robert; Cheah, Chan Y; MacManus, Michael; Matigian, Nicholas; Mollee, Peter; Gandhi, Maher K; Hapgood, Greg |
| 17 | 2019 | Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. | Wight, Joel C ; Yue, Mimi; Keane, Colm; Johnston, Anna; Linton, Kim; Chin, Collin; Wai, Shin Hnin; Talaulikar, Dipti; Gasiorowski, Robin; Cheah, Chan Yoon; Gregory, Gareth P; Dickinson, Michael; Minson, Adrian; Coombes, Caitlin; Ku, Matthew; Lam, Stephanie; Hawkes, Eliza A |
| 18 | 10-Mar-2016 | Overall survival and durable responses in patients with BRAF V600–mutant metastatic melanoma receiving dabrafenib combined with trametinib | Long, Georgina V; Weber, Jeffrey s; Infante, Jeffrey R; Kim, Kevin B; Daud, Adil; Gonzalez, Rene; Sosman, Jeffrey A; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan S ; Kefford, Richard F; Lawrence, Donald P; Kudchadkar, Ragini; Burris, Howard A; Falchook, Gerald S; Algazi, Alain; Lewis, Karl; Puzanov, Igor; Ibrahim, Nageatte; Sun, Peng; Cunningham, Elizabeth; Kline, Amy S; Del Buono, Heather; McDowell, Diane Opatt; Patel, Kiran; Flaherty, Keith T |
| 19 | Jan-2024 | Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. | Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Buteau, James P; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew J ; Scott, Andrew M ; Lee, Sze Ting ; Kwan, Edmond M; Azad, Arun A; Ramdave, Shakher; Redfern, Andrew D; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Yan; Stockler, Martin R; Williams, Scott G; Martin, Andrew J; Davis, Ian D |
| 20 | 5-Oct-2017 | Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. | Wolchok, Jedd D; Chiarion-Sileni, Vanna; Gonzalez, Rene; Rutkowski, Piotr; Grob, Jean-Jacques; Cowey, C Lance; Lao, Christopher D; Wagstaff, John; Schadendorf, Dirk; Ferrucci, Pier F; Smylie, Michael; Dummer, Reinhard; Hill, Andrew; Hogg, David; Haanen, John; Carlino, Matteo S; Bechter, Oliver; Maio, Michele; Marquez-Rodas, Ivan; Guidoboni, Massimo; McArthur, Grant; Lebbé, Celeste; Ascierto, Paolo A; Long, Georgina V; Cebon, Jonathan S ; Sosman, Jeffrey; Postow, Michael A; Callahan, Margaret K; Walker, Dana; Rollin, Linda; Bhore, Rafia; Hodi, F Stephen; Larkin, James |
